Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53.
about
Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical featuresGene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathwaysChallenges in the Diagnosis and Management of Well-Differentiated Neuroendocrine Tumors of the Lung (Typical and Atypical Carcinoid): Current Status and Future ConsiderationsInducible nitric oxide synthase (iNOS) activity promotes ischaemic skin flap survivalNitric oxide regulates lung carcinoma cell anoikis through inhibition of ubiquitin-proteasomal degradation of caveolin-1Involvement of oxidatively damaged DNA and repair in cancer development and aging.An analysis of trends and growth factor receptor expression of GI carcinoid tumorsPhosphorylated TP63 induces transcription of RPN13, leading to NOS2 protein degradationThe not-so innocent bystander: the microenvironment as a therapeutic target in cancer.Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumourCarcinoid--a comprehensive review.A Biomimic Reconstituted High-Density-Lipoprotein-Based Drug and p53 Gene Co-delivery System for Effective Antiangiogenesis Therapy of Bladder CancerExpression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic adenocarcinoma: correlation with microvessel density.Vascular endothelial growth factor promotes the expression of cyclooxygenase 2 and matrix metalloproteinases in Lewis lung carcinoma cellsInfrequent p53 gene mutation and expression of the cardia adenocarcinomas from a high-incidence area of Southwest China.Expression of inducible nitric oxide synthase in healthy pleura and in malignant mesotheliomaEmerging therapies for the treatment of patients with advanced neuroendocrine tumors.Actinic cheilitis and squamous cell carcinoma of the lip: clinical, histopathological and immunogenetic aspects.The yin and yang of nitric oxide in cancer progression.Alveolar Macrophage Polarisation in Lung Cancer.Treatment with the nitric oxide synthase inhibitor L-NAME provides a survival advantage in a mouse model of Kras mutation-positive, non-small cell lung cancer.Endothelial nitric oxide synthase is strongly expressed in malignant mesothelioma but does not associate with vascular density or the expression of VEGF, FLK1 or FLT1.Established Principles and Emerging Concepts on the Interplay between Mitochondrial Physiology and S-(De)nitrosylation: Implications in Cancer and Neurodegeneration.MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1.MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma.Quantitative measurement of m-RNA levels to assess expression of cyclooxygenase-II, inducible nitric oxide synthase and 12-lipoxygenase genes in middle ear cholesteatoma.Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors.Hypoxia in biology and medicine: the legacy of L H Gray.
P2860
Q24792085-6B50F50A-9EF3-4FB0-AD0B-742E20296FE6Q26821895-B7677C25-5655-4B08-8A6D-7AD84F1D7E99Q28084155-76DE21E2-2345-4965-A1A5-E7F016795256Q28362996-3A8C4773-0002-4A95-862E-16151F921296Q28392426-52F34205-B2ED-44A4-A713-608599D234F2Q33942077-C088E9EC-50C2-47B1-B978-C7127A8E6F08Q33985773-4063D6FF-C3A8-486F-BDD2-AD9816B7D09CQ34438764-4797C54F-EE8C-4DFF-AD98-EE01B31D82D6Q35056031-E068C541-D949-44C3-AF47-702F525D49D9Q35588624-589AAC95-2E12-45AA-8C23-92AF9BD81C95Q35613499-95D58411-A832-409A-8795-5E6910A21082Q35686513-8D9BD32C-B41A-415B-BFCC-8306C24A7632Q36065891-08F5A68F-3319-42BD-8266-59DC3B575374Q36386639-61E2FA7C-2116-473F-A255-8B94E1565ADCQ36397737-D476C2DE-D0AB-40C1-BFD6-5A33CAF9E74EQ36642288-87C58322-733B-4E15-A85E-7B35E3DC2A31Q36866607-FCB0B350-0EE2-4215-85A8-D8F1533801FEQ38000538-269451CE-5A7B-4054-8DB1-35F5ACBB95B2Q38077081-06028C02-17D8-4046-8D31-B335B011EB81Q38575761-3225845E-B27C-48EF-9AFA-3AEBE9D963A3Q39543819-C70C33CC-6EE5-4152-9BFF-AC0E6D6964B8Q40787693-8B70745C-0797-4D12-BEFC-1C3F22C56F2CQ41918404-AC530340-E178-4A7D-9A5A-5337BC61EEF3Q42630303-07E7F0ED-1FE7-410F-8C14-BA16A0477D2DQ43184280-932CA4B2-B029-4ED6-A3D7-40FB400A6BBAQ43802965-1287411B-FDFB-4778-937A-6B3AFC3C4CF3Q48344252-B79EE43C-CF63-47E3-8EDB-0984FCDE2445Q48592806-84E38ECB-EFBF-41CC-B55A-AD3327EF167F
P2860
Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Vascular endothelial growth fa ...... ancer and the relation to p53.
@ast
Vascular endothelial growth fa ...... ancer and the relation to p53.
@en
type
label
Vascular endothelial growth fa ...... ancer and the relation to p53.
@ast
Vascular endothelial growth fa ...... ancer and the relation to p53.
@en
prefLabel
Vascular endothelial growth fa ...... ancer and the relation to p53.
@ast
Vascular endothelial growth fa ...... ancer and the relation to p53.
@en
P2093
P2860
P356
P1476
Vascular endothelial growth fa ...... cancer and the relation to p53
@en
P2093
C C Harris
M O Ogunfusika
W G Merriam
W P Bennett
P2860
P2888
P304
P356
10.1038/BJC.1998.470
P407
P577
1998-07-01T00:00:00Z